These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2010759)

  • 1. Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder?
    Leys D; Pruvo JP; Parent M; Vermersch P; Soetaert G; Steinling M; Delacourte A; Défossez A; Rapoport A; Clarisse J
    J Neurol Neurosurg Psychiatry; 1991 Jan; 54(1):46-50. PubMed ID: 2010759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is leuko-araiosis in Alzheimer's disease, in Parkinson's disease and in healthy elderly persons the result of Wallerian degeneration?].
    Leys D; Pruvo JP; Soetaert G; Vermersch P; Rapoport A; Clarisse J; Petit H
    Acta Neurol Belg; 1989; 89(3-4):249-52. PubMed ID: 2516973
    [No Abstract]   [Full Text] [Related]  

  • 3. Leuko-araiosis.
    Verny M; Duyckaerts C; Pierot L; Hauw JJ
    Dev Neurosci; 1991; 13(4-5):245-50. PubMed ID: 1817028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of leuko-araiosis with cerebral atrophy and perfusion in elderly normal subjects and demented patients.
    Kawamura J; Meyer JS; Ichijo M; Kobari M; Terayama Y; Weathers S
    J Neurol Neurosurg Psychiatry; 1993 Feb; 56(2):182-7. PubMed ID: 8437007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leuko-araiosis and cerebral hypoperfusion compared in elderly normals and Alzheimer's dementia.
    Kawamura J; Meyer JS; Terayama Y; Weathers S
    J Am Geriatr Soc; 1992 Apr; 40(4):375-80. PubMed ID: 1556365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis).
    Steingart A; Hachinski VC; Lau C; Fox AJ; Fox H; Lee D; Inzitari D; Merskey H
    Arch Neurol; 1987 Jan; 44(1):36-9. PubMed ID: 3800720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leuko-araiosis, cerebral atrophy, and cerebral perfusion in normal aging.
    Kobari M; Meyer JS; Ichijo M
    Arch Neurol; 1990 Feb; 47(2):161-5. PubMed ID: 2302088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis).
    Steingart A; Hachinski VC; Lau C; Fox AJ; Diaz F; Cape R; Lee D; Inzitari D; Merskey H
    Arch Neurol; 1987 Jan; 44(1):32-5. PubMed ID: 3800719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leuko-araiosis and cerebral perfusion in normal aging.
    Kawamura J; Terayama Y; Takashima S; Obara K; Pavol MA; Meyer JS; Mortel KF; Weathers S
    Exp Aging Res; 1993; 19(3):225-40. PubMed ID: 8223824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood flow differences between leuko-araiosis with and without lacunar infarction.
    Oishi M; Mochizuki Y; Takasu T
    Can J Neurol Sci; 1998 Feb; 25(1):70-5. PubMed ID: 9532285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathologic correlates of leuko-araiosis.
    Janota I; Mirsen TR; Hachinski VC; Lee DH; Merskey H
    Arch Neurol; 1989 Oct; 46(10):1124-8. PubMed ID: 2803072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular risk factors and leuko-araiosis.
    Inzitari D; Diaz F; Fox A; Hachinski VC; Steingart A; Lau C; Donald A; Wade J; Mulic H; Merskey H
    Arch Neurol; 1987 Jan; 44(1):42-7. PubMed ID: 3800721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
    Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in regional cerebral blood flow in two types of leuko-araiosis.
    Oishi M; Mochizuki Y
    J Neurol Sci; 1999 Apr; 164(2):129-33. PubMed ID: 10402023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leuko-araiosis and event-related potentials (P300) in normal aged subjects.
    Yamashita K; Kobayashi S; Fukuda H; Yamaguchi S; Koide H
    Gerontology; 1992; 38(4):233-40. PubMed ID: 1427121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leuko-araiosis: description and clinical correlates.
    Smith RR; Hendrie HC
    Compr Ther; 1992 Jan; 18(1):7-16. PubMed ID: 1737450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of leuko-araiosis.
    Tarvonen-Schröder S; Röyttä M; Räihä I; Kurki T; Rajala T; Sourander L
    J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):431-6. PubMed ID: 8774411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leuko-Araiosis and cerebral hypoperfusion compared between patients with ischemic vascular dementia and normal elderly volunteers.
    Kawamura J; Meyer JS; Terayama Y; Weathers S
    J Stroke Cerebrovasc Dis; 1992; 2(4):180-8. PubMed ID: 26486828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brain water diffusion coefficients and diffusion anisotropy in non-demented patients with diffuse leuko-araiosis].
    Tsuganesawa T; Igarashi H; Kitamura S; Terashi A
    Nihon Ika Daigaku Zasshi; 1998 Apr; 65(2):167-72. PubMed ID: 9594553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.